| Authors: |
Burkhart DL; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Morel KL; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Sheahan AV; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Richards ZA; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Ellis L; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA. leigh_ellis@dfci.harvard.edu.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. leigh_ellis@dfci.harvard.edu.; The Broad Institute, Cambridge, MA, USA. leigh_ellis@dfci.harvard.edu. |
